Skip to main content

oritavancin (TenkasiĀ®)

 

Appraisal in progress

Indication

Status: In progress

Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.

Medicine details

Medicine name oritavancin (TenkasiĀ®)
Formulation 400 mg powder for concentrate for solution for infusion
Reference number 5023
Indication

As above

Company Menarini UK
BNF chapter Infections
Submission type Full
Status In progress
NMG meeting date 02/03/2022
AWMSG meeting date 27/04/2022
Date of issue TBC